Send a textAre you looking to launch a new medical technology, medical or diagnostic device in the UK, Europe or North America? Would you like to know how health economic modelling could support your market access journey?In this episode, converted from a recent live webinar, Calum Jones (Consultant Health Economist) and Nick Swart (Senior Health Economist) discuss what, why and how health economic models can support MedTech innovations to demonstrate value, achieve market access and reach more patients.Health economic modelling is becoming a key component of the MedTech market access journey. There is increasing need in many countries to demonstrate economic evidence for new technologies, with many health technology assessment (HTA) bodies now requiring economic models before offering guidance for reimbursement, such as NICE’s Medical Technology Evaluation Programme (MTEP). MedTech firms are also recognising that a cost effectiveness model can also offer robust evidence of interventional value to support discussions with payers and other healthcare stakeholders.In this episode, Calum and Nick share their complementary perspectives and experiences of helping MedTech companies achieve market access.Please email [email protected] for a copy of Calum and Nick's slides or to find out more about how Mtech Access can support your market access journey.Learn more about our Health Economics services here: https://mtechaccess.co.uk/health-economics/ Learn more about our work with Medtech companies here: https://mtechaccess.co.uk/medtech-market-access/ Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related